Crossmark

COL6A2 in clear cell renal cell carcinoma: a multifaceted driver of tumor progression, immune evasion, and drug sensitivity

Published Online: 2025-08-06

Authors

Yang, Yashuang

Fan, Ruixin

Zhang, Boming

Liu, Kai https://orcid.org/0000-0002-4152-1975
Funding

Funding for this research was provided by:

Natural Science Foundation of Shandong Province (ZR2024QH382)
License Information

Text and Data Mining valid from 2025-08-06

Version of Record valid from 2025-08-06
More Information

Article History

Received: 9 April 2025

Accepted: 22 June 2025

First Online: 6 August 2025

Declarations

:

: For animal study: This study was approved by the Medical Ethics Committee of Zhongnan Hospital, Wuhan University (approval MRI2024-LAC209). For human study: not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current